Cannabis Watch: HHS recommends rescheduling cannabis, and stocks in the sector rally
Bloomberg reports that the Department of Health and Human Services is pushing to move cannabis to Schedule III from Schedule I for potential medical use.
Market Extra: Asset managers and hedge funds are increasingly taking different positions in the U.S. Treasury market
Asset managers and hedge funds are increasingly taking different positions inside the most liquid government-securities market in the world — and the gulf has only gotten wider this month."
In One Chart: This chart helped a group of stock-market analysts predict that August’s stock-market selloff wouldn’t last
A handful of market watchers correctly surmised that the August pullback in U.S. stocks wouldn't metastasize into a more painful, enduring selloff. How did they...
: Mitch McConnell appears to freeze again, in another health scare for Senate’s top Republican
Senate Minority Leader Mitch McConnell freezes Wednesday during an event in Kentucky, with the incident coming a month after a similar freeze-up.
: Deere & Co. raises quarterly dividend to $1.35 a share vs. $1.25 previously
Deere & Co. DE said Wednesday its board has approved an increase in its quarterly dividend to $1.35 a share from $1.25 previously. The maker...
: Baidu stock jumps as China-based search engine’s generative AI product Ernie is now open to the public
Shares of Baidu Inc. BIDU rallied 4.0% in afternoon trading Wednesday, after the China-based internet search and online marketing company said its generative artificial-intelligence (AI)...
: McConnell appears to freeze again
Senate Minority Leader Mitch McConnell froze for about 30 seconds during an event in Kentucky on Wednesday afternoon that was recorded by a local TV...
: Apple testing use of 3D printers for future smartwatch cases: report
Apple Inc. AAPL is thinking differently when it comes to how they produce the cases for their Apple Watch, according to a report Wednesday. Bloomberg...
Medicare drug price negotiations may have a muted impact on drugmakers in the near term
Many of the drugs are already facing strong competition from other branded medications or patent expirations that will open the market to generic alternatives.